EW
Edwards Lifesciences
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: EW
- PE Ratio
As of Jun 22, 2026, the Edwards Lifesciences stock's PE ratio is 45.44. This takes into account the latest EPS of $1.89 and stock price of $85.88. The PE ratio has grown by 37% from its last 4 quarters average of 33.2.
EW PE ratio history
The PE ratio of Edwards Lifesciences has averaged 40.82 over the last ten years. The current P/E ratio of 45.44 is 11% higher than the historical average. Looking back at the last ten years, EW's PE ratio peaked in the Dec 2020 quarter at 69.11, when the price was $91.23 and the EPS was $1.32. The lowest point was in the Sep 2024 quarter, when it reached 9.51 with a price of $65.99 and an EPS of $6.94.
Edwards Lifesciences PE ratio by year
Maximum annual increase: 336.66% in 2025
Maximum annual decrease: -67.86% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 46.33 | 336.66% | $85.25 | $1.84 |
| 2024 | 10.61 | -67.86% | $74.03 | $6.98 |
| 2023 | 33.01 | 8.84% | $76.25 | $2.31 |
| 2022 | 30.33 | -43.58% | $74.61 | $2.46 |
| 2021 | 53.76 | -22.21% | $129.55 | $2.41 |
| 2020 | 69.11 | 49.3% | $91.23 | $1.32 |
| 2019 | 46.29 | 4.26% | $77.76 | $1.68 |
| 2018 | 44.4 | 8.72% | $51.06 | $1.15 |
| 2017 | 40.84 | 16.39% | $37.57 | $0.92 |
| 2016 | 35.09 | 2.63% | $31.23 | $0.89 |
| 2015 | 34.19 | 104.49% | $26.33 | $0.77 |
| 2014 | 16.72 | -11.53% | $21.23 | $1.27 |
| 2013 | 18.9 | -47.18% | $10.96 | $0.58 |
| 2012 | 35.78 | 6.27% | $15.03 | $0.42 |
| 2011 | 33.67 | -20.02% | $11.78 | $0.35 |
Edwards Lifesciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 42.37 | -8.55% | $80.08 | $1.89 |
| Dec 2025 | 46.33 | 40.01% | $85.25 | $1.84 |
| Sep 2025 | 33.09 | 195.71% | $77.77 | $2.35 |
| Jun 2025 | 11.19 | 8.54% | $78.21 | $6.99 |
| Mar 2025 | 10.31 | -2.83% | $72.48 | $7.03 |
| Dec 2024 | 10.61 | 11.57% | $74.03 | $6.98 |
| Sep 2024 | 9.51 | -74.98% | $65.99 | $6.94 |
| Jun 2024 | 38.01 | -7.32% | $92.37 | $2.43 |
| Mar 2024 | 41.01 | 24.24% | $95.56 | $2.33 |
| Dec 2023 | 33.01 | 11.97% | $76.25 | $2.31 |
| Sep 2023 | 29.48 | -29.07% | $69.28 | $2.35 |
| Jun 2023 | 41.56 | 21.06% | $94.33 | $2.27 |
| Mar 2023 | 34.33 | 13.19% | $82.73 | $2.41 |
| Dec 2022 | 30.33 | -14.1% | $74.61 | $2.46 |
| Sep 2022 | 35.31 | -13.12% | $82.63 | $2.34 |
EW Price vs fair value
EW average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, EW's PE ratio is higher than the 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 45.44, EW ranks higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 24.1, Edwards Lifesciences's price to earnings (P/E) is 89% higher.
EW PE vs peers
EW's PE ratio stands lower than its peer stock ICUI, but it is higher than MDT's and BSX's. Edwards Lifesciences is currently trading at a higher PE ratio (45.44) than its peers average of 34.55.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BSX Boston Scientific Corp | 18.83 | $67.44B |
| MDT Medtronic plc | 21.39 | $102.67B |
| MMSI Merit Medical Systems Inc | 28.64 | $4.01B |
| LMAT Lemaitre Vascular Inc | 33.34 | $2.1B |
| EW Edwards Lifesciences Corp | 45.6 | $49.62B |
| ICUI Icu Medical Inc | 73.06 | $3.41B |
Frequently asked questions
What is Edwards Lifesciences's PE ratio?
The price to earnings ratio for EW stock as of Jun 22, 2026, stands at 45.44.
What is the 3-year average PE ratio for Edwards Lifesciences (EW)?
The 3-year average price to earnings ratio for EW stock is 28.87.
What is the 5-year average PE ratio for Edwards Lifesciences (EW)?
The 5-year average price to earnings ratio for EW stock is 34.02.
What is the highest PE ratio for EW?
The highest quarterly PE ratio in the last ten years has been 69.11 and it was in the Dec 2020 quarter.
How does the current PE ratio for EW compare to its historical average?
EW's price to earnings ratio is currently 11% above its 10-year historical average.
How is EW's PE ratio calculated (Edwards Lifesciences PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 22, 2026), Edwards Lifesciences's share price is $85.88. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.89. Therefore, Edwards Lifesciences's PE ratio for today is 45.44. PE RATIO(45.44) = STOCK PRICE($85.88) / TTM EPS($1.89)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.